Tesla Motors Inc (TSLA) Looking to Hit Another All-Time High

TheStreet‘s Jonathan Marino said Tesla Motors Inc (NASDAQ:TSLA) stock has been showing an attractive growth of about 75 % so far for the year 2014, opening the possibility of reaching a global maximum on the stock’s price curve. Its current value is at around $263.

Tesla Motors Inc (NASDAQ:TSLA)

This piece of news not only makes the small drop in stock price during 2013 look insignificant, but accompanied with the company’s intention of producing 100,000 new cars in 2015 paves great possibilities for the electric car maker. Besides, on August 15 Elon Musk, the CEO of Tesla Motors Inc (NASDAQ:TSLA), presented the company’s plan of extending the Infinite Mile Warranty on the 85 kWh Model S up to eight years. Although, this decision might hinder earnings in the short term, it might hopefully push them up in the long term’s perspective.

The existing models could enjoy a series of new improved features. “The company is looking to bring in security experts to make a safer, possibly unhackable car.”, Elon Musk was quoted as saying.

 Also, there was an announcement, regarding development of a 500-mile graphene battery, that created a lot of fuss. No date of release seems to be available, but there are sources mentioning the possibility of Tesla Motors Inc (NASDAQ:TSLA) actually working on implementing graphene’s potential. Skeptically, many point the fact that graphene production hasn’t even started and it bears some issues with it, particularly health concerns and cost problems (the material is not cheap).

Disregarding these ambiguous stories, a Gigafactory specialized in the production of cylindrical lithium-ion cell batteries is going to be built by the electric vehicle giant in corroboration with Panasonic. Thus, Tesla Motors Inc (NASDAQ:TSLA) is not only experimenting, but planning seriously a stable future for the company and the customers.

 Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!